Electron Transport Chain: The Engine of Cellular Energy

The electron transport chain (ETC) stands as a pivotal metabolic pathway, orchestrating a series of redox reactions that culminate in the production of ATP, the cell’s energy currency. This intricate system, a cornerstone of oxidative phosphorylation, is located within the mitochondria of eukaryotic cells, powering cellular respiration, and in the chloroplasts of plant cells, driving photosynthesis. In cellular respiration, the ETC harnesses energy from the breakdown of nutrient molecules, while in photosynthesis, it captures light energy to fuel carbohydrate synthesis.

Fundamentals of the Electron Transport Chain

Aerobic cellular respiration, the process by which cells derive energy from nutrients, unfolds in three key stages: glycolysis, the citric acid cycle (Krebs cycle), and oxidative phosphorylation. Glycolysis initiates the breakdown of glucose into pyruvate, yielding a modest amount of ATP and NADH. Pyruvate then undergoes further processing to acetyl CoA, generating additional NADH and carbon dioxide (CO2). Acetyl CoA enters the citric acid cycle, a cyclic series of reactions that produce CO2, NADH, FADH2, and a small amount of ATP. Oxidative phosphorylation, the final and most prolific stage, utilizes the NADH and FADH2 generated in the preceding steps to produce water and a substantial quantity of ATP.

Oxidative phosphorylation itself is a two-part process encompassing the electron transport chain (ETC) and chemiosmosis. The ETC is a sequence of protein complexes embedded in the inner mitochondrial membrane, alongside mobile electron carriers. Electrons are passed along this chain through a series of redox reactions, releasing energy at each transfer. This released energy is strategically used to pump protons across the inner mitochondrial membrane, establishing a proton gradient. Chemiosmosis then harnesses this proton gradient to drive ATP synthase, a molecular machine that synthesizes large quantities of ATP.

Photosynthesis, the process by which plants and other organisms convert light energy into chemical energy, also relies on an electron transport chain. During the light-dependent reactions of photosynthesis, light energy and water are used to generate ATP, NADPH, and oxygen (O2). Similar to cellular respiration, a proton gradient, formed by an electron transport chain within the thylakoid membranes of chloroplasts, is crucial for ATP production in photosynthesis. The ATP and NADPH produced in the light-dependent reactions are then used in the light-independent reactions (Calvin cycle) to synthesize sugars.

The Electron Transport Chain at the Cellular Level

Within the electron transport chain (ETC), electrons are transferred through a series of protein complexes, each exhibiting an increasingly positive reduction potential. This stepwise transfer of electrons is exergonic, meaning it releases energy. A significant portion of this released energy is captured and utilized to actively transport hydrogen ions (H+) from the mitochondrial matrix to the intermembrane space, creating an electrochemical gradient, also known as a proton gradient. This gradient manifests as a higher concentration of protons (increased acidity) in the intermembrane space and an electrical potential difference, with a positive charge on the intermembrane space side and a negative charge on the matrix side of the inner mitochondrial membrane. The major protein complexes of the ETC, in the sequence of electron flow, are Complex I, Complex II, Coenzyme Q, Complex III, Cytochrome c, and Complex IV.

• Complex I (NADH Dehydrogenase): This complex, also known as NADH-CoQ reductase, serves as the initial entry point for electrons derived from NADH, a crucial electron carrier generated in glycolysis and the citric acid cycle. Complex I accepts electrons from NADH and transfers them to coenzyme Q (ubiquinone). This electron transfer is coupled to the pumping of protons from the mitochondrial matrix to the intermembrane space, contributing to the proton gradient. Specifically, for every pair of electrons transferred from NADH to coenzyme Q, Complex I pumps four protons across the membrane.

• Complex II (Succinate Dehydrogenase): Complex II, also known as succinate-CoQ reductase, provides an alternative entry point for electrons into the ETC. This complex accepts electrons from FADH2, another key electron carrier produced in the citric acid cycle. Succinate dehydrogenase catalyzes the oxidation of succinate to fumarate in the citric acid cycle, and in this process, electrons are transferred to FAD within Complex II. FAD then passes these electrons through iron-sulfur (Fe-S) clusters to coenzyme Q. Importantly, unlike Complex I, Complex II does not directly pump protons across the inner mitochondrial membrane during electron transfer. This means that the pathway through Complex II results in the production of less ATP compared to the pathway through Complex I.

  • Reaction within Complex II: Succinate + FAD → Fumarate + 2 H+(matrix) + FADH2
  • Electron transfer to CoQ: FADH2 + CoQ → FAD + CoQH2

• Coenzyme Q (Ubiquinone): Coenzyme Q, often abbreviated as CoQ or Q and also known as ubiquinone, is a small, mobile electron carrier. It is a quinone molecule with a long hydrophobic tail, allowing it to diffuse within the inner mitochondrial membrane. Coenzyme Q acts as a crucial link, accepting electrons from both Complex I and Complex II, and transferring them to Complex III. Coenzyme Q can exist in three redox states: fully oxidized ubiquinone (Q), partially reduced semiquinone radical (CoQH-), and fully reduced ubiquinol (CoQH2). The interconversion between these states, particularly the reduction of ubiquinone to ubiquinol, is central to its function in electron transport. The Q cycle, further detailed under Complex III, elaborates on the role of coenzyme Q in proton translocation.

• Complex III (Cytochrome bc1 complex): Complex III, also known as CoQ-cytochrome c reductase or cytochrome bc1 complex, mediates the transfer of electrons from ubiquinol (CoQH2) to cytochrome c. This complex plays a pivotal role in both electron transport and proton pumping. Complex III operates via the Q cycle, a sophisticated mechanism that not only facilitates electron transfer but also contributes to the proton gradient. In the Q cycle, for every two electrons transferred to cytochrome c, four protons are translocated across the inner mitochondrial membrane – two protons are pumped from the matrix to the intermembrane space, and two protons are consumed from the matrix.

• Cytochrome c: Cytochrome c is a small, mobile protein that acts as an electron carrier between Complex III and Complex IV. Unlike the membrane-bound complexes, cytochrome c is a peripheral membrane protein located in the intermembrane space. It carries electrons from Complex III to Complex IV, effectively bridging these two large protein complexes.

• Complex IV (Cytochrome c Oxidase): Complex IV, also known as cytochrome c oxidase, is the final protein complex in the electron transport chain. It accepts electrons from cytochrome c and catalyzes the reduction of molecular oxygen (O2) to water (H2O). This reaction is the terminal step of the ETC in cellular respiration, and it is essential for aerobic life. Complex IV is a proton pump, and for every four electrons passed through Complex IV to reduce one molecule of O2, it pumps two protons from the mitochondrial matrix to the intermembrane space. The reduction of oxygen by Complex IV is a highly regulated process, ensuring efficient energy production and minimizing the generation of harmful reactive oxygen species.

• ATP Synthase (Complex V): ATP synthase, also known as Complex V, is not directly involved in electron transport but is functionally coupled to the ETC. It harnesses the proton gradient generated by Complexes I, III, and IV to synthesize ATP. ATP synthase is a remarkable molecular machine composed of two main subunits: F0 and F1. The F0 subunit is embedded within the inner mitochondrial membrane and forms a channel through which protons can flow down their electrochemical gradient, from the intermembrane space back to the matrix. This proton flow drives the rotation of the F0 subunit, which in turn causes conformational changes in the F1 subunit. The F1 subunit, located in the mitochondrial matrix, contains the catalytic sites for ATP synthesis. The rotational energy from F0 is converted into chemical energy as ADP and inorganic phosphate (Pi) are combined to form ATP within the F1 subunit. It is estimated that for every four protons that pass through ATP synthase, one molecule of ATP is generated. Interestingly, ATP synthase can also operate in reverse under certain conditions, using ATP hydrolysis to pump protons against their gradient, although this is not its primary physiological role in mitochondria.

Molecular Level Insights: NADH and FADH2 in the ETC

Nicotinamide adenine dinucleotide (NAD) and flavin adenine dinucleotide (FAD) are critical coenzymes that act as electron carriers in cellular metabolism. They exist in oxidized (NAD+ and FAD) and reduced (NADH and FADH2) forms. NADH and FADH2 are generated during glycolysis, the citric acid cycle, and fatty acid oxidation, and they serve as the primary electron donors to the electron transport chain.

• NADH: Nicotinamide adenine dinucleotide (NAD+) is a dinucleotide composed of two nucleotides linked by phosphate groups. One nucleotide contains an adenine base, and the other contains nicotinamide, a derivative of vitamin B3 (niacin). In metabolic redox reactions, NAD+ acts as an oxidizing agent, accepting two electrons and one proton to become NADH (Reaction 1).

  • Reaction 1: RH2 + NAD+ → R + H+ + NADH (where RH2 is a reduced substrate, and R is its oxidized form)

  NADH enters the electron transport chain at Complex I. As electrons are transferred from NADH through the ETC to oxygen, protons are pumped across the inner mitochondrial membrane at Complexes I, III, and IV. It is estimated that the transfer of electrons from one NADH molecule through the entire ETC results in the pumping of approximately 10 protons (4 from Complex I, 4 from Complex III, and 2 from Complex IV). Given that ATP synthase requires approximately 4 protons to synthesize one ATP molecule, the oxidation of one NADH molecule theoretically yields about 2.5 ATP molecules (10 H+ / 4 H+ per ATP = 2.5 ATP). (Note: some sources round this value to 3 ATP). When NADH is oxidized in Complex I, it is converted back to NAD+, releasing a proton and two electrons (Reaction 2), which then enter the ETC.

  • Reaction 2: NADH → H+ + NAD+ + 2 e-

• FADH2: Flavin adenine dinucleotide (FAD) is another crucial redox cofactor. It has four redox states, with the fully oxidized form being FAD (quinone), the partially reduced form being FADH- (semiquinone), and the fully reduced form being FADH2 (hydroquinone). FAD is composed of an adenine nucleotide and flavin mononucleotide (FMN), linked by phosphate groups. FMN is derived in part from vitamin B2 (riboflavin). FAD contains a stable aromatic ring system in its oxidized form, while FADH2 does not. The oxidation of FADH2 to FAD (Reaction 3) is an exergonic process, releasing energy that is harnessed in the ETC. FAD is a stronger oxidizing agent than NAD+, with a more positive reduction potential.

  • Reaction 3: FADH2 → FAD + 2 H+ + 2 e-

  FADH2 enters the electron transport chain at Complex II. Since Complex II does not pump protons, the electron transfer pathway from FADH2 bypasses Complex I’s proton pumping activity. Electrons from FADH2 are transferred through Complex II, Coenzyme Q, Complex III, and Complex IV, leading to proton pumping only at Complexes III and IV. The oxidation of one FADH2 molecule is estimated to result in the pumping of approximately 6 protons (4 from Complex III and 2 from Complex IV). Therefore, the oxidation of one FADH2 molecule theoretically yields about 1.5 ATP molecules (6 H+ / 4 H+ per ATP = 1.5 ATP). (Note: some sources round this to 2 ATP).

  In addition to its role in the ETC, FAD participates in various metabolic pathways outside of oxidative phosphorylation, including fatty acid beta-oxidation, DNA repair, and the synthesis of other essential coenzymes like CoA, CoQ, and heme.

Clinical Significance: Disruptions of the Electron Transport Chain

The electron transport chain is a critical system for cellular energy production, and disruptions to its function can have significant clinical consequences. Two major categories of disruptions are uncoupling agents and inhibitors of oxidative phosphorylation.

• Uncoupling Agents: Uncoupling agents are substances that disrupt the tight coupling between the electron transport chain and ATP synthesis by ATP synthase. They essentially make the inner mitochondrial membrane leaky to protons. These agents dissipate the proton gradient by providing an alternative pathway for protons to flow back into the mitochondrial matrix, bypassing ATP synthase. As a result, the energy released by electron transport is dissipated as heat rather than being used to synthesize ATP.

  When uncoupling agents are present, the electron transport chain becomes hyperactive in an attempt to maintain the proton gradient and continue ATP production. However, because protons are leaking across the membrane, ATP synthase cannot effectively utilize the gradient. This leads to a decrease in ATP production and an increase in heat generation, as the energy from electron transport is released as heat. Cellular ATP depletion can trigger metabolic stress, and the increased heat production can lead to hyperthermia. Furthermore, cells may shift to anaerobic metabolism (fermentation) to compensate for the reduced ATP production, potentially resulting in lactic acidosis.

  • Examples of Uncoupling Agents:
    • Aspirin (Salicylic Acid): At high doses, aspirin can act as an uncoupling agent, disrupting the phospholipid bilayer of mitochondrial membranes and increasing proton permeability.
    • Thermogenin: Thermogenin, also known as uncoupling protein 1 (UCP1), is a natural uncoupling agent found in brown adipose tissue. It allows protons to leak across the inner mitochondrial membrane, generating heat instead of ATP. This process, known as non-shivering thermogenesis, is crucial for heat production in newborns and hibernating animals.

• Oxidative Phosphorylation Inhibitors: A variety of toxins and drugs can inhibit specific components of the electron transport chain or ATP synthase, blocking electron flow or ATP synthesis.

  • Examples of ETC Inhibitors:

    • Rotenone: Rotenone, a natural insecticide, inhibits Complex I by blocking the transfer of electrons from iron-sulfur clusters to coenzyme Q.
    • Carboxin: Carboxin, a fungicide, also inhibits Complex II at the coenzyme Q binding site, similar to rotenone.
    • Antimycin A: Antimycin A, a piscicide, inhibits Complex III by binding to the Qi site of cytochrome c reductase, preventing ubiquinone binding and disrupting the Q cycle.
    • Cyanide (CN-) and Carbon Monoxide (CO): Cyanide and carbon monoxide are potent inhibitors of Complex IV (cytochrome c oxidase). They bind to the heme iron in cytochrome oxidase, preventing the binding of oxygen and blocking the final step of electron transport. Cyanide poisoning can result from exposure to house fire smoke, jewelry cleaning solutions, industrial processes, and even certain fruit seeds. Carbon monoxide poisoning is commonly associated with incomplete combustion of fuels.
    • Oligomycin: Oligomycin is an inhibitor of ATP synthase (Complex V). It binds to the F0 subunit of ATP synthase, blocking the proton channel and preventing proton flow, thereby inhibiting ATP synthesis.

  • Clinical Implications of ETC Inhibitors: Inhibition of the ETC can rapidly deplete cellular ATP levels, leading to cellular dysfunction and potentially cell death. The specific clinical manifestations depend on the inhibitor and the extent of ETC disruption. Cyanide poisoning, for example, can cause tissue hypoxia, metabolic acidosis, and a characteristic almond odor on the breath. Carbon monoxide poisoning also leads to hypoxia by preventing oxygen delivery to tissues. Treatment for cyanide poisoning may involve nitrites to induce methemoglobinemia, which binds cyanide, and thiosulfate or hydroxocobalamin to detoxify cyanide. Oligomycin and other ATP synthase inhibitors can induce apoptosis (programmed cell death).

Disruptions of the electron transport chain underscore its vital role in cellular life and highlight the clinical relevance of mitochondrial function and dysfunction in various diseases and toxicities.

References

1.Lencina AM, Franza T, Sullivan MJ, Ulett GC, Ipe DS, Gaudu P, Gennis RB, Schurig-Briccio LA. Type 2 NADH Dehydrogenase Is the Only Point of Entry for Electrons into the Streptococcus agalactiae Respiratory Chain and Is a Potential Drug Target. mBio. 2018 Jul 03;9(4) [PMC free article: PMC6030563] [PubMed: 29970468]

2.Hirst J. Towards the molecular mechanism of respiratory complex I. Biochem J. 2009 Dec 23;425(2):327-39. [PubMed: 20025615]

3.Sazanov LA, Hinchliffe P. Structure of the hydrophilic domain of respiratory complex I from Thermus thermophilus. Science. 2006 Mar 10;311(5766):1430-6. [PubMed: 16469879]

4.Hirst J. Energy transduction by respiratory complex I–an evaluation of current knowledge. Biochem Soc Trans. 2005 Jun;33(Pt 3):525-9. [PubMed: 15916556]

5.Yankovskaya V, Horsefield R, Törnroth S, Luna-Chavez C, Miyoshi H, Léger C, Byrne B, Cecchini G, Iwata S. Architecture of succinate dehydrogenase and reactive oxygen species generation. Science. 2003 Jan 31;299(5607):700-4. [PubMed: 12560550]

6.Horsefield R, Iwata S, Byrne B. Complex II from a structural perspective. Curr Protein Pept Sci. 2004 Apr;5(2):107-18. [PubMed: 15078221]

7.Geertman JM, van Maris AJ, van Dijken JP, Pronk JT. Physiological and genetic engineering of cytosolic redox metabolism in Saccharomyces cerevisiae for improved glycerol production. Metab Eng. 2006 Nov;8(6):532-42. [PubMed: 16891140]

8.Thorpe C, Kim JJ. Structure and mechanism of action of the acyl-CoA dehydrogenases. FASEB J. 1995 Jun;9(9):718-25. [PubMed: 7601336]

9.Sun C, Benlekbir S, Venkatakrishnan P, Wang Y, Hong S, Hosler J, Tajkhorshid E, Rubinstein JL, Gennis RB. Structure of the alternative complex III in a supercomplex with cytochrome oxidase. Nature. 2018 May;557(7703):123-126. [PMC free article: PMC6004266] [PubMed: 29695868]

10.Iwata S, Lee JW, Okada K, Lee JK, Iwata M, Rasmussen B, Link TA, Ramaswamy S, Jap BK. Complete structure of the 11-subunit bovine mitochondrial cytochrome bc1 complex. Science. 1998 Jul 03;281(5373):64-71. [PubMed: 9651245]

11.Trumpower BL. The protonmotive Q cycle. Energy transduction by coupling of proton translocation to electron transfer by the cytochrome bc1 complex. J Biol Chem. 1990 Jul 15;265(20):11409-12. [PubMed: 2164001]

12.Hunte C, Palsdottir H, Trumpower BL. Protonmotive pathways and mechanisms in the cytochrome bc1 complex. FEBS Lett. 2003 Jun 12;545(1):39-46. [PubMed: 12788490]

13.Calhoun MW, Thomas JW, Gennis RB. The cytochrome oxidase superfamily of redox-driven proton pumps. Trends Biochem Sci. 1994 Aug;19(8):325-30. [PubMed: 7940677]

14.Schmidt-Rohr K. Oxygen Is the High-Energy Molecule Powering Complex Multicellular Life: Fundamental Corrections to Traditional Bioenergetics. ACS Omega. 2020 Feb 11;5(5):2221-2233. [PMC free article: PMC7016920] [PubMed: 32064383]

15.Lovero D, Giordano L, Marsano RM, Sanchez-Martinez A, Boukhatmi H, Drechsler M, Oliva M, Whitworth AJ, Porcelli D, Caggese C. Characterization of Drosophila ATPsynC mutants as a new model of mitochondrial ATP synthase disorders. PLoS One. 2018;13(8):e0201811. [PMC free article: PMC6086398] [PubMed: 30096161]

16.Okuno D, Iino R, Noji H. Rotation and structure of FoF1-ATP synthase. J Biochem. 2011 Jun;149(6):655-64. [PubMed: 21524994]

17.Junge W, Nelson N. ATP synthase. Annu Rev Biochem. 2015;84:631-57. [PubMed: 25839341]

18.Hinkle PC. P/O ratios of mitochondrial oxidative phosphorylation. Biochim Biophys Acta. 2005 Jan 07;1706(1-2):1-11. [PubMed: 15620362]

19.Barrett MA, Zheng S, Roshankar G, Alsop RJ, Belanger RK, Huynh C, Kučerka N, Rheinstädter MC. Interaction of aspirin (acetylsalicylic acid) with lipid membranes. PLoS One. 2012;7(4):e34357. [PMC free article: PMC3328472] [PubMed: 22529913]

20.Warrick BJ, King A, Smolinske S, Thomas R, Aaron C. A 29-year analysis of acute peak salicylate concentrations in fatalities reported to United States poison centers. Clin Toxicol (Phila). 2018 Sep;56(9):846-851. [PubMed: 29431532]

21.Cinti S. The adipose organ. Prostaglandins Leukot Essent Fatty Acids. 2005 Jul;73(1):9-15. [PubMed: 15936182]

22.Enerbäck S. The origins of brown adipose tissue. N Engl J Med. 2009 May 07;360(19):2021-3. [PubMed: 19420373]

23.Zhou W, Faraldo-Gómez JD. Membrane plasticity facilitates recognition of the inhibitor oligomycin by the mitochondrial ATP synthase rotor. Biochim Biophys Acta Bioenerg. 2018 Sep;1859(9):789-796. [PMC free article: PMC6176861] [PubMed: 29630891]

24.Kamalian L, Douglas O, Jolly CE, Snoeys J, Simic D, Monshouwer M, Williams DP, Kevin Park B, Chadwick AE. The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity. Toxicol In Vitro. 2018 Dec;53:136-147. [PubMed: 30096366]

25.Wood DM, Alsahaf H, Streete P, Dargan PI, Jones AL. Fatality after deliberate ingestion of the pesticide rotenone: a case report. Crit Care. 2005 Jun;9(3):R280-4. [PMC free article: PMC1175899] [PubMed: 15987402]

26.Lupescu A, Jilani K, Zbidah M, Lang F. Induction of apoptotic erythrocyte death by rotenone. Toxicology. 2012 Oct 28;300(3):132-7. [PubMed: 22727881]

27.Wallace KB. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol. 2003 Sep;93(3):105-15. [PubMed: 12969434]

28.Weaver LK. Clinical practice. Carbon monoxide poisoning. N Engl J Med. 2009 Mar 19;360(12):1217-25. [PubMed: 19297574]

29.Sato K, Tamaki K, Hattori H, Moore CM, Tsutsumi H, Okajima H, Katsumata Y. Determination of total hemoglobin in forensic blood samples with special reference to carboxyhemoglobin analysis. Forensic Sci Int. 1990 Nov;48(1):89-96. [PubMed: 2279722]

30.Barker SJ, Tremper KK. The effect of carbon monoxide inhalation on pulse oximetry and transcutaneous PO2. Anesthesiology. 1987 May;66(5):677-9. [PubMed: 3578881]

31.Raub JA, Mathieu-Nolf M, Hampson NB, Thom SR. Carbon monoxide poisoning–a public health perspective. Toxicology. 2000 Apr 07;145(1):1-14. [PubMed: 10771127]

32.Jensen P, Wilson MT, Aasa R, Malmström BG. Cyanide inhibition of cytochrome c oxidase. A rapid-freeze e.p.r. investigation. Biochem J. 1984 Dec 15;224(3):829-37. [PMC free article: PMC1144519] [PubMed: 6098268]

33.Shchepina LA, Pletjushkina OY, Avetisyan AV, Bakeeva LE, Fetisova EK, Izyumov DS, Saprunova VB, Vyssokikh MY, Chernyak BV, Skulachev VP. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene. 2002 Nov 21;21(53):8149-57. [PubMed: 12444550]